|
Quotes & Info
|
| BMRN > SEC Filings for BMRN > Form 8-K on 24-Nov-2008 | All Recent SEC Filings |
24-Nov-2008
Change in Directors or Principal Officers, Financial Statements and E
On November 21, 2008, BioMarin Pharmaceutical Inc. (the "Company") announced that Dr. Emil Kakkis, its Chief Medical Officer will retire from the Company on February 27, 2009. The Company's press release issued on November 21, 2008 is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
(d) Exhibits.
|
|